Otsuka to stop development of Alzheimer’s disease drug

(Reuters) – Japan’s Otsuka Pharmaceutical said on Wednesday it will stop development of its experimental drug to treat patients with agitation associated with Alzheimer’s disease.

(Reporting by Mariam Sunny in Bengaluru; Editing by Maju Samuel)